From prescription-only (Rx) to over-the-counter (OTC) status in Germany 2006–2015: pharmacological perspectives on regulatory decisions
Crossref DOI link: https://doi.org/10.1007/s00228-017-2240-4
Published Online: 2017-03-28
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Barrenberg, Eva
Garbe, Edeltraut
License valid from 2017-03-28